Brief: Compugroup Medical Q1 Adj. EBITDA Margin at 20.6%
10/05/2023 06:30
May 10 (Reuters) - Compugroup Medical Outlook FY adjusted EBITDA EUR 260-300 million. * Q1 adjusted EBITDA EUR 60 million * Q1 adjusted EBITDA margin 20.6%
Recent news on CompuGroup Medical SE & Co KgaA
See all newsBrief: Nagarro to replace CompuGroup in Germany's TecDax, Stratec in SDAX
Brief: Compugroup Medical Delisting Effective 24 June 2025
Brief: Compugroup Medical SE & Co KGaA - Issues Joint Reasoned Statement Recommending Shareholders To Accept Cvc's Public Delisting Offer
Brief: Cvc Capital Partners - Acceptance Period For Public Delisting Offer To Shareholders Of Compugroup Begins
Brief: Caesar Bidco Says Intends To Offer Cash Consideration In Amount Of Eur 22.00 Per CompuGroup Medical Share